Related Experiment Video
Updated: Feb 8, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
[Research Progress on the Role of Pyroptosis in the Pathogenesis of Myelodysplastic Syndrome -Review]
Ying Lin1, Qing-Ping Gao1, Bai-Xin Ye1
1Department of Hematology, People's Hospital of Wuhan University, Wuhan 430060, Hubei Province, China.
Abstract:
Pyroptosis is a novel type of programmed cell death, which is closely related with the pathogenesis of myelodysplastic syndromes (MDS). The recent studies showed that all of S100A9/TLR4, S100A9/CD33 and Nox/ROS signaling pathways can activate oxygen-sensitivity NLRP3 inflammasome and then induce the pyroptosis of hematopoeitic stem cells (HSC) / hematopeitic pregenitor cells (HPC), resulting in ineffective hematopoiesis in patients with MDS. Further studies on the role and molecular mechanism of pyroptosis in the pathogenesis of MDS will provide the potential opportunity for the diagnosis and treatment of MDS. Here, the recent advances in the role and mechnism of pyroptosis in the pathogenesis of MDS are reviewed.
Insights
Pyroptosis, a programmed cell death, contributes to myelodysplastic syndromes (MDS) by triggering ineffective hematopoiesis via NLRP3 inflammasome activation in hematopoietic stem cells.
Area of Science:
- Cell Biology
- Hematology
- Immunology
Background:
- Pyroptosis is a programmed cell death mechanism implicated in various diseases.
- Myelodysplastic syndromes (MDS) are characterized by ineffective hematopoiesis.
- Emerging evidence links pyroptosis to the pathogenesis of MDS.
Purpose of the Study:
- To review the recent advances in understanding the role of pyroptosis in MDS pathogenesis.
- To elucidate the molecular mechanisms underlying pyroptosis in MDS.
- To highlight the potential of pyroptosis as a diagnostic and therapeutic target for MDS.
Main Methods:
- Literature review of recent studies on pyroptosis and MDS.
- Analysis of signaling pathways involved in pyroptosis activation in hematopoietic stem cells (HSC) and hematopoietic progenitor cells (HPC).
- Examination of the connection between pyroptosis and ineffective hematopoiesis in MDS.
Main Results:
- S100A9/TLR4, S100A9/CD33, and Nox/ROS signaling pathways activate the NLRP3 inflammasome.
- NLRP3 inflammasome activation induces pyroptosis in HSC/HPC.
- Pyroptosis contributes to ineffective hematopoiesis in MDS patients.
Conclusions:
- Pyroptosis plays a significant role in the pathogenesis of MDS.
- Understanding pyroptosis mechanisms offers potential for MDS diagnosis and treatment.
- Targeting pyroptosis pathways may provide novel therapeutic strategies for MDS.
Related Concept Videos
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

